SCHEMBL1382102

SCHEMBL1382102

O=C(c1nccn1-c1ccccc1)N1CCN(c2cccc(Cl)c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.60
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HTR1A P08908 1/20 0.54
HTR2A P28223 1/20 0.54
HTR7 P34969 1/20 0.54
HTR6 P50406 1/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA9 Q16790 1/20 0.53
HTT P42858 3/20 0.53
TSHR P16473 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
USP2 O75604 1/20 0.53
MAPT P10636 1/20 0.53
LMNA P02545 2/20 0.53
MAPK1 P28482 1/20 0.53
NPC1 O15118 1/20 0.53
ALOX15 P16050 1/20 0.53
RAB9A P51151 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27997623 0.82 HPGD (0.46) ALDH1A1MEN1KMT2AHTTTSHR
SCHEMBL6263437 0.81 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL5764010 0.77 FNTA (0.59) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL6266820 0.76 ALDH1A1 (0.60) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL12835479 0.76 ALDH1A1 (1.00) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL1458090 0.75 HTR1A (0.73) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL5788590 0.75 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AHTTTSHR
SCHEMBL31051381 0.74 MAPT (0.59) ALDH1A1MEN1KMT2ATSHRUSP2
SCHEMBL9646111 0.73 ALDH1A1 (0.73) ALDH1A1MEN1KMT2AHTR1AHTR2A
SCHEMBL27167239 0.73 ALDH1A1 (0.64) ALDH1A1MEN1KMT2AHTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4805813-B2 2011-11-02 JP claimed
EP-1641765-A1 ARYL-HETEROAROMATIC PRODUCTS, COMPOSITIONS CONTAINING SAME AND USE THEREOF Aventis Pharma S.A. (FR) 2006-04-05 EP claimed
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AVENTIS PHARMA S.A. (FR) 2005-01-20 US claimed
WO-2004108685-A1 ARYL-HETEROAROMATIC PRODUCTS, COMPOSITIONS CONTAINING SAME AND USE THEREOF AVENTIS PHARMA S.A. (FR) 2004-12-16 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AHR, ARNT, MYC ALDH1A1 240/4885MEN1 1456/4885KMT2A 658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.